- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03601208
Mitra v Fingerprick Tacrolimus Creatinine
August 6, 2018 updated by: Nottingham University Hospitals NHS Trust
Comparison of Standard Venous Sampling for Measurement of Tacrolimus and Creatinine Versus Fingerprick Mitra® Volumetric Absorptive Microsampling in Adult Renal Transplant Recipients
Patients with kidney transplant have blood tests very often.
This is normally done in hospital and using a needle inserted into the vein.
Two tests are important for kidney transplant patients - creatinine to monitor the health of the kidney; and tacrolimus to measure the level of the medicine which prevents rejection.
The investigators would like to compare a fingerprick microsampling method to the standard venous blood.
The fingerprick test is the same done by patients with diabetes and we use a microsampling tip which looks like a cotton bud to draw up a small amount of blood.
Each tip draws up exactly 10 microlitres which is two drops.
The investigators want to compare the results of creatinine and tacrolimus done through the two methods.
In the future, this would allow patients to do their creatinine and tacrolimus test at home.
The tips dry completely and can be posted to a laboratory.
We hope this will make life easier for transplant patients and also help them engage more with the care of their condition.
Study Overview
Study Type
Interventional
Enrollment (Anticipated)
100
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
Kidney transplant recipients. Taking tacrolimus
Exclusion Criteria:
Unable to consent
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Blood sample
Venepuncture vs fingerprick test using Mitra volumetric absorptive microsampling (VAMs)
|
When the patients have their bloods done through venepuncture, an additional 5-10mls will be taken (one EDTA bottle for tacrolimus and one serum bottle for creatinine; and two Mitra VAMs).
Patients will also have a fingerprick test and 20 microlitres of blood taken using Mitra volumetric absorptive microsampling (VAMs)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Comparison of creatinine and tacrolimus values for Mitra VAM (test) versus venous sampling (standard).
Time Frame: 3 months
|
Compare blood results for creatinine and tacrolimus using two different methods - Mitra volumetric absorptive microsamplers (VAM) versus venous blood (standard).
|
3 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Anticipated)
August 1, 2018
Primary Completion (Anticipated)
October 1, 2018
Study Completion (Anticipated)
January 1, 2019
Study Registration Dates
First Submitted
June 25, 2018
First Submitted That Met QC Criteria
July 17, 2018
First Posted (Actual)
July 26, 2018
Study Record Updates
Last Update Posted (Actual)
August 8, 2018
Last Update Submitted That Met QC Criteria
August 6, 2018
Last Verified
June 1, 2018
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 18RE007
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Transplant;Failure,Kidney
-
University of GuadalajaraInstituto Mexicano del Seguro SocialActive, not recruitingKidney Transplant Failure | Kidney TransplantMexico
-
University of MinnesotaWithdrawnKidney Transplant Rejection | Kidney Transplant; Complications | Kidney Transplant FailureUnited States
-
University of Erlangen-Nürnberg Medical SchoolCharite University, Berlin, Germany; University Hospital, EssenActive, not recruitingKidney Transplant Rejection | Kidney Transplant FailureGermany
-
Hospital de Clinicas de Porto AlegreActive, not recruitingKidney Transplant Infection | Kidney Transplant Rejection | Kidney Transplant Failure | Kidney Transplant Failure and RejectionBrazil
-
University of British ColumbiaCanadian Institutes of Health Research (CIHR)Not yet recruitingKidney Transplant Failure | Kidney Transplant | ImmunosuppresionCanada
-
Universitaire Ziekenhuizen KU LeuvenActive, not recruitingKidney Transplantation | Kidney Transplant Rejection | Kidney Transplant FailureBelgium
-
California Institute of Renal ResearchUniversity of California, San Diego; Balboa Institute of TransplantationRecruitingKidney Transplant; Complications | Kidney Transplant Failure and RejectionUnited States
-
Charite University, Berlin, GermanyCompletedKidney Transplant Rejection | Antibody-mediated Rejection | Kidney Transplant FailureGermany
-
Université Catholique de LouvainUnknownImmunosuppression | Kidney Transplant; Complications | Transplant FailureBelgium
-
University of MinnesotaCompletedKidney Transplant Rejection | Kidney Transplant; Complications | Transplant; Complication, Rejection | Kidney Transplant Failure and Rejection | Transplant DysfunctionUnited States
Clinical Trials on Mitra
-
Deutsches Herzzentrum MuenchenUnknown
-
Children's Hospital Medical Center, CincinnatiCompletedValidate Volumetric Absorptive Microsampling (VAMS) AssayUnited States
-
Nottingham University Hospitals NHS TrustCompletedImmunosuppressionUnited Kingdom
-
Institut CurieNot yet recruiting
-
University Hospital, GrenobleRecruitingMetabolic Diseases | PhenylketonuriaFrance
-
Lancashire Teaching Hospitals NHS Foundation TrustSuspendedUtilising Volumetric Absorptive Microsampling (VAMS) Technology to Monitor Tacrolimus and CreatinineKidney Transplant Rejection | Kidney ReplacementUnited Kingdom
-
University of Colorado, DenverNational Institute of Allergy and Infectious Diseases (NIAID)RecruitingHIV Prevention | HIV TreatmentUnited States
-
University Hospital, CaenRecruitingAdult Acute Myeloid LeukemiaFrance